{"title":"Spontaneous giant chest wall hematomas in COVID-19 patients: case report","authors":"Á. Fuentes-Martín, Ángel Cilleruelo Ramos, J. Soro-García, José María Matilla González","doi":"10.21037/shc-21-29","DOIUrl":null,"url":null,"abstract":"Background: Spontaneous chest wall hematomas are an extremely rare clinical finding. Bleeding manifestations without other associated factors have not yet been re-ported in COVID-19 disease. Case Description: We report the cases of two patients with severe COVID-19 disease who debuted with a giant spontaneous chest wall hematoma at our institution without a history of traumatic event or previous invasive procedure. Both patients, a 75-year-old male and a 96-year-old woman, were in a resolution stage of their COVID-19 bilateral pneumonia and were receiving prophylactic dose low-molecular-weight heparin. The initial symptoms in both patients were the appearance of chest pain with a rapidly progressive indurated mass in the pectoral region. The imaging test of choice were computed chest tomography and an angiographic study, which allowed the identification of the possible origin of the bleeding and its subsequent selective embolization. Surgical drainage of the hematoma was necessary in one of the patients. Both patients presented a good clinical evolution, being able to be discharged from the hospital approximately one week after admission, with hematoma in the resolution phase and without clinical, laboratory or radiological data of active bleeding. Conclusions: We consider it necessary to individualize antithrombotic prophylaxis in COVID-19 disease until the risk-benefit ratio is delimited. © 2022 by Prusa Medical Publishing.","PeriodicalId":74794,"journal":{"name":"Shanghai chest","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shanghai chest","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/shc-21-29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
COVID-19患者自发性巨大胸壁血肿1例
背景:自发性胸壁血肿是一种极为罕见的临床表现。无其他相关因素的出血表现在COVID-19疾病中尚未报道。病例描述:我们报告了两例重症COVID-19患者,他们在我院首次出现巨大的自发性胸壁血肿,没有创伤事件史或先前的侵入性手术。两名患者,一名75岁男性和一名96岁女性,均处于COVID-19双侧肺炎的缓解阶段,并正在接受预防性剂量低分子肝素治疗。两例患者的初始症状均为胸痛并伴胸区迅速进展的硬化肿块。选择的影像学检查是胸部计算机断层扫描和血管造影研究,这可以确定出血的可能来源和随后的选择性栓塞。其中1例患者需要手术引流血肿。两例患者均表现出良好的临床进展,入院后约一周即可出院,血肿处于消退期,无活动性出血的临床、实验室或放射学资料。结论:我们认为在确定风险-收益比之前,有必要对COVID-19疾病进行个体化抗血栓预防。©2022 by Prusa Medical Publishing。
本文章由计算机程序翻译,如有差异,请以英文原文为准。